Brodin, N P, Munck Af Rosenschold, P, Aznar, M C
et al. Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma. Acta Oncol
2011; 50 (6): 806–816.
GLOBOCAN. GLOBOCAN 1: cancer incidence and mortality worldwide. J Clin Pathol
2000; 53 (2): 164.
Lopez Guerra, J L, Marrone, I, Jaen, J
et al. Outcome and toxicity using helical tomotherapy for craniospinal irradiation in pediatric medulloblastoma. Clin Transl Oncol
2014; 16 (1): 96–101.
Packer, R J, Gajjar, A, Vezina, G
et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol
2006; 24 (25): 4202–4208.
Ostrom, Q T, Gittleman, H, Liao, P
et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro Oncol
2014; 16 (suppl 4): iv1–iv63.
Fossati, P, Ricardi, U, Orecchia, R. Pediatric medulloblastoma: toxicity of current treatment and potential role of protontherapy. Cancer Treat Rev
2009; 35 (1): 79–96.
Myers, P A, Mavroidis, P, Papanikolaou, N, Stathakis, S. Comparing conformal, arc radiotherapy and helical tomotherapy in craniospinal irradiation planning. J Appl Clin Med Phys
2014; 15 (5): 4724.
Barrett, A. Practical Radiotherapy Planning, 4th edition. London: Hodder Arnold, 2009; viii, 468 pp., 20–21, 214–215.
Penagaricano, J, Moros, E, Corry, P, Saylors, R, Ratanatharathorn, V. Pediatric craniospinal axis irradiation with helical tomotherapy: patient outcome and lack of acute pulmonary toxicity. Int J Radiat Oncol Biol Phys
2009; 75 (4): 1155–1161.
Huang, F, Parker, W, Freeman, C R. Feasibility and early outcomes of supine-position craniospinal irradiation. Pediatr Blood Cancer
2010; 54 (2): 322–325.
Parker, W, Brodeur, M, Roberge, D, Freeman, C. Standard and nonstandard craniospinal radiotherapy using helical TomoTherapy. Int J Radiat Oncol Biol Phys
2010; 77 (3): 926–931.
Sugie, C, Shibamoto, Y, Ayakawa, S
et al. Craniospinal irradiation using helical tomotherapy: evaluation of acute toxicity and dose distribution. Technol Cancer Res Treat
2011; 10 (2): 187–195.
TomoTherapy Treatment System. Tomo Planning Guide 105191A TomoHD Version 1.0.x. Madison, WI: TomoTherapy Incorporated, 2010.
Kim, J, Jeong, K, Chung, Y
et al. Feasibility of TomoDirect 3D-conformal radiotherapy for craniospinal irradiation. Int J Radiat Oncol
2010; 78 (3): S828.
Langner, U W, Molloy, J A, Gleason, J F Jr, Feddock, J M. A feasibility study using TomoDirect for craniospinal irradiation. J Appl Clin Med Phys
2013; 14 (5): 104–114.
Patil, V M, Oinam, A S, Chakraborty, S, Ghoshal, S, Sharma, S C. Shielding in whole brain irradiation in the multileaf collimator era: dosimetric evaluation of coverage using SFOP guidelines against in-house guidelines. J Cancer Res Ther
2010; 6 (2): 152–158.
Patel, S, Drodge, S, Jacques, A, Warkentin, H, Powell, K, Chafe, S. A comparative planning analysis and integral dose of volumetric modulated arc therapy, helical tomotherapy, and three-dimensional conformal craniospinal irradiation for pediatric medulloblastoma. J Med Imaging Radiat Sci
2015; 46: 134–140.
Nakamura, N, Shikama, N, Wada, H
et al. Variability in the point to which single direct field irradiation is prescribed for spinal bone metastases: a survey of practice patterns in Japan. J Radiat Res
2013; 54 (6): 1065–1068.
Gupta, T, Sarin, R. Palliative radiation therapy for painful vertebral metastases: a practice survey. Cancer
2004; 101 (12): 2892–2896.
Marks, L B, Yorke, E D, Jackson, A
et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys
2010; 76 (3 suppl): S10–S19.
Roesink, J M, Moerland, M A, Battermann, J J, Hordijk, G J, Terhaard, C H. Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region. Int J Radiat Oncol Biol Phys
2001; 51 (4): 938–946.
Verellen, D, Vanhavere, F. Risk assessment of radiation-induced malignancies based on whole-body equivalent dose estimates for IMRT treatment in the head and neck region. Radiother Oncol
1999; 53 (3): 199–203.
Yoon, M, Shin, D H, Kim, J
et al. Craniospinal irradiation techniques: a dosimetric comparison of proton beams with standard and advanced photon radiotherapy. Int J Radiat Oncol Biol Phys
2011; 81 (3): 637–646.
Mayneord, W V. The measurement of radiation for medical purposes. Proceedings of the Physical Society, 1942; 54: 405–421.
Nguyen, F, Rubino, C, Guerin, S
et al. Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: correlation with the integral dose restricted to the irradiated fields. Int J Radiat Oncol Biol Phys
2008; 70 (3): 908–915.
Hall, E J, Wuu, C S. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys
2003; 56 (1): 83–88.
Barra, S, Gusinu, M, Cavagnetto, F
et al. Comparison of treatment plans between 3D-CRT and helical tomotherapy based on integral dose delivered to pediatric patients receiving craniospinal irradiation. Int J Radiat Oncol Biol Phys
2010; 78 (3): S594.
Sharma, D S, Gupta, T, Jalali, R, Master, Z, Phurailatpam, R D, Sarin, R. High-precision radiotherapy for craniospinal irradiation: evaluation of three-dimensional conformal radiotherapy, intensity-modulated radiation therapy and helical TomoTherapy. Br J Radiol
2009; 82 (984): 1000–1009.
Stovall, M, Smith, S A, Langholz, B M
et al. Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys
2008; 72 (4): 1021–1030.
Srivastava, R, Saini, G, Sharma, P K
et al. A technique to reduce low dose region for craniospinal irradiation (CSI) with RapidArc and its dosimetric comparison with 3D conformal technique (3DCRT). J Cancer Res Ther
2015; 11 (2): 488–491.